Literature DB >> 10378360

Does Helicobacter pylori infection contribute to gastroesophageal reflux disease?

S J Spechler1.   

Abstract

Helicobacter pylori organisms that infect the stomach conceivably could contribute to esophageal inflammation in patients with gastroesophageal reflux disease (GERD) through any of at least three potential mechanisms: 1) by causing an increase in gastric acid secretion; 2) by spreading to infect the gastric-type columnar epithelium that occasionally can line the distal esophagus; and/or 3) by secreting noxious bacterial products into the gastric juice. Studies regarding these potential mechanisms are discussed in this report. Most investigations have found no apparent association between H. pylori infection and reflux esophagitis. Presently, infection with H. pylori does not appear to play an important role in the pathogenesis of GERD.

Entities:  

Mesh:

Year:  1998        PMID: 10378360      PMCID: PMC2578887     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  34 in total

1.  Effect of once daily intravenous and oral omeprazole on 24-hour intragastric acidity in healthy subjects.

Authors:  C Cederberg; K Röhss; P Lundborg; L Olbe
Journal:  Scand J Gastroenterol       Date:  1993-02       Impact factor: 2.423

2.  Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation.

Authors:  P R Tarnasky; T O Kovacs; B Sytnik; J H Walsh
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

Review 3.  Intestinal metaplasia of the stomach. A status report.

Authors:  G N Stemmermann
Journal:  Cancer       Date:  1994-07-15       Impact factor: 6.860

4.  Esophagitis and Helicobacter pylori in children: incidence and therapeutic implications.

Authors:  C Rosioru; M S Glassman; M S Halata; S M Schwarz
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

5.  Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases.

Authors:  W Tee; J R Lambert; B Dwyer
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

Review 6.  The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.

Authors:  J H Walsh; W L Peterson
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

7.  Prevalence of metaplasia at the gastro-oesophageal junction.

Authors:  S J Spechler; J M Zeroogian; D A Antonioli; H H Wang; R K Goyal
Journal:  Lancet       Date:  1994-12-03       Impact factor: 79.321

8.  Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole.

Authors:  E F Verdú; D Armstrong; R Fraser; F Viani; J P Idström; C Cederberg; A L Blum
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

9.  Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.

Authors:  E M el-Omar; I D Penman; J E Ardill; R S Chittajallu; C Howie; K E McColl
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

10.  Helicobacter pylori and gastro-oesophageal reflux disease--a prospective study.

Authors:  H J O'Connor; K Cunnane
Journal:  Ir J Med Sci       Date:  1994-08       Impact factor: 1.568

View more
  3 in total

1.  The relationship between helicobacter pylori infection and gastro-esophageal reflux disease.

Authors:  Batool M Mahdi
Journal:  N Am J Med Sci       Date:  2011-03

2.  Does a relationship still exist between gastroesophageal reflux and Helicobacter pylori in patients with reflux symptoms?

Authors:  Michele Grande; Giorgio Lisi; Flavio De Sanctis; Simona Grande; Alessia Esser; Michela Campanelli; Valerio Balassone; Giovanni Milito; Massimo Villa
Journal:  World J Surg Oncol       Date:  2014-12-06       Impact factor: 2.754

3.  The association between helicobacter pylori infection and erosive gastroesophageal reflux disease; a cross-sectional study.

Authors:  Ramin Niknam; Kamran Bagheri Lankarani; Mohsen Moghadami; Seyed Alireza Taghavi; Leila Zahiri; Mohammad Javad Fallahi
Journal:  BMC Infect Dis       Date:  2022-03-19       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.